Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp
about
Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive HealthTreatment challenges for urogenital and anorectal Chlamydia trachomatisPreclinical evaluation of novel antibacterial agents by microbiological and molecular techniquesLipooligosaccharide is required for the generation of infectious elementary bodies in Chlamydia trachomatis.Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS/MS).Nitropropenyl benzodioxole, an anti-infective agent with action as a protein tyrosine phosphatase inhibitorEffects of a probiotic strain of Enterococcus faecium on the rate of natural chlamydia infection in swine.Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp.High frequency of chlamydial co-infections in clinically healthy sheep flocks.Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatisCandidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis.In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.Rifalazil pretreatment of mammalian cell cultures prevents subsequent Chlamydia infection.Antibiotic resistance in Chlamydiae.A cohort study of Chlamydia trachomatis treatment failure in women: a study protocol.Chloramphenicol acetyltransferase as a selection marker for chlamydial transformationInhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infectionComparing azithromycin and doxycycline for the treatment of rectal chlamydial infection: a retrospective cohort studyAnalyses of the pathways involved in early- and late-phase induction of IFN-beta during C. muridarum infection of oviduct epithelial cellsTrachoma decline and widespread use of antimicrobial drugs.Approaches to the management of uncomplicated genital Chlamydia trachomatis infections.Differences in 23S ribosomal RNA mutations between wild-type and mutant macrolide-resistant Chlamydia trachomatis isolates.Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in WomenTherapeutic approaches to Chlamydia infections.Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2.Pharmacokinetics of a single 1g dose of azithromycin in rectal tissue in men.Development potential of rifalazil and other benzoxazinorifamycins.The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection.Chlamydia Serine Protease Inhibitor, targeting HtrA, as a New Treatment for Koala Chlamydia infection.Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae.Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachomaHorizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene.Novel Detection Strategy To Rapidly Evaluate the Efficacy of Antichlamydial Agents.Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.Tet(C) Gene Transfer between Chlamydia suis Strains Occurs by Homologous Recombination after Co-infection: Implications for Spread of Tetracycline-Resistance among Chlamydiaceae.Demonstration of Persistent Infections and Genome Stability by Whole-Genome Sequencing of Repeat-Positive, Same-Serovar Chlamydia trachomatis Collected From the Female Genital Tract.Azithromycin Treatment Failure for Chlamydia trachomatis Among Heterosexual Men With Nongonococcal Urethritis.
P2860
Q21284727-B551836E-8554-4845-80F9-A8AC5C9F717DQ26798290-BC04BFA2-DD79-407D-89CB-C8402B57840DQ28273315-9CEDB4F1-2574-455E-9E4C-BD45BEEED65CQ30501560-CFA7250B-1104-43CE-BCF6-0E707224AE11Q33675064-FCADA0B9-3840-4423-BEB5-3134675D4F09Q33815443-1EEAD51B-68CA-4159-BCF8-2AA8E4F5053EQ33883364-22ADB5DF-9D5A-49B9-9FF9-67416B3B3777Q33883747-4BB701F0-EB48-4A47-9641-391C6EABEAD6Q33934505-EEF55B2D-C24F-49FB-B6DB-E99C53C19688Q33935250-56AE2C42-11EE-4142-BFEB-41E76146B538Q33987702-B56411A7-70E1-4874-A72B-33FE0EB524C3Q34007328-BEB38E9E-6A15-4E3C-8D5F-FB777D7BA52EQ34123772-45390414-F00E-4C31-86E5-29AA765749E2Q34141733-76274035-AC24-4BFC-931B-32405F9E1CDBQ34352208-28EDF626-6187-4E26-8749-58385BAB2DE4Q34784830-EFBC7A6E-DD5F-44C9-8AFB-EED173010D59Q34955571-F0D6A3C4-D644-4D5A-9111-0CE2506033CEQ34995727-4E485FE1-543D-48FA-B058-FD6A6936AE49Q35073899-147FAE6B-B7A3-4C68-BB7D-9889683C6F5DQ35190494-0CD18AC7-5426-4002-A55A-558146CF4C7DQ35208728-23E40E84-F00F-459F-B594-7F9A5FBD3162Q35895991-6B373B16-E3F2-4CF0-B53B-D0E57D8E585CQ35917551-27AC6C13-C96F-41C0-A2FA-F749F34CE31EQ35942887-0337BCC7-67CE-408D-A256-EAE61BE38D5BQ35992863-45627C23-05D2-4889-9985-39A61D9ADC4FQ36283735-66E71AE7-AA90-4D80-8141-3F8FC850727DQ36313199-CB89718E-6C8C-4272-9909-7E6763C05AE0Q36325324-5069D014-07DC-496E-AFB6-BE33E21D0220Q36491823-050B3E26-5E8F-4C71-AD99-DE5D89F92B04Q36551190-E74DBF6D-7104-427C-806E-987C6CBC8840Q37181409-A605585D-05B9-4251-A6FA-2C5F483B2CC4Q37204183-98157D0A-161B-43E6-A5D3-8DF8A10F276AQ37347419-45342292-F882-42D8-8C7B-9CAA20B0291DQ37409961-07BF5D9B-922D-42F8-8298-51588E0F54C8Q37568967-086C6EAC-9648-4EE1-B6E2-AECECD8D7F72Q37612922-1DE76E26-F1FF-4F14-809A-E966358F970DQ37624924-9711C23A-8E95-4C78-8480-E61F025DE022Q37627187-249BA7DE-22DD-470A-AE09-6B08093C860EQ37834533-EB0EC682-851D-46D2-9FFA-74B35991437DQ37835694-912E46E7-261A-4799-84B9-AA5BEE4CB7F0
P2860
Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Methodologies and cell lines u ...... ility testing of Chlamydia spp
@ast
Methodologies and cell lines u ...... ility testing of Chlamydia spp
@en
Methodologies and cell lines u ...... ility testing of Chlamydia spp
@nl
type
label
Methodologies and cell lines u ...... ility testing of Chlamydia spp
@ast
Methodologies and cell lines u ...... ility testing of Chlamydia spp
@en
Methodologies and cell lines u ...... ility testing of Chlamydia spp
@nl
prefLabel
Methodologies and cell lines u ...... ility testing of Chlamydia spp
@ast
Methodologies and cell lines u ...... ility testing of Chlamydia spp
@en
Methodologies and cell lines u ...... ility testing of Chlamydia spp
@nl
P2093
P2860
P1476
Methodologies and cell lines u ...... ility testing of Chlamydia spp
@en
P2093
R J Suchland
W M Geisler
Walter E Stamm
P2860
P304
P356
10.1128/AAC.47.2.636-642.2003
P407
P577
2003-02-01T00:00:00Z